Sangamo BioSciences with $100M secondary

|About: Sangamo Therapeutics, Inc. (SGMO)|By:, SA News Editor

After a 72% run YTD, Sangamo BioSciences (SGMO) decides to raise some capital, offering $100M of new stock with an underwriter greenshoe for 15% of that amount.

Shares -2.2% AH